III . I:


III II 25 (18 ) 19 73 .

Annotation
To study in detail electrophysiological properties of Niferidil, a novel III-class antiarrhythmic manufactured in Russia, 25 patients including 18 men aged 19 73 years with documented paroxysms of supraventricular tachycardia were examined during a Phase II clinical trial.



, . ., , . ., , . ., , . ., , . ., , . ., , . ., , . ., , . .


-70 01/12/2012, . 5 /..